After the hopeful interim results publisheda few week ago , US biotech firm Moderna account the concluding findings from the phase 3 test of its Covid-19 vaccinum . The overall efficacy of the vaccine is 94.1 percent ( a tenuous modification from the interim answer ) with an efficacy against severe Covid-19 of 100 percent .
The run had 30,000 US participants , half of which were given two venereal disease of the vaccine ( four week apart ) and the other one-half were give a placebo . During the trial , 196 people developed Covid-19 , of which 185 were in the placebo group and 11 in the vaccine group . Thirty of the cases in the placebo group experience severe Covid-19 symptoms and there were no severe cases in the vaccinum group .
“ This prescribed primary analysis confirms the power of our vaccine to foreclose Covid-19 disease with 94.1 % efficacy and significantly , the ability to prevent hard Covid-19 disease . We think that our vaccine will ply a new and powerful tool that may change the trend of this pandemic and help prevent severe disease , hospitalization and death , ” Stéphane Bancel , principal executive military officer of Moderna , said in astatement .
The company has submitted this data point to the European Medicines Agency ( EMA ) and to the US Food and Drug Administration ( FDA ) for review and commendation . The society wait an solution from the FDA during a meeting on December 17 .
As seen in the interim data point , the vaccine is well tolerated with no reports of significant side outcome . The most common effect are fatigue , headache , muscle painful sensation , as well as botheration and inflammation around the injection site . They are similar to the one you might experience when receiving the flu vaccinum .
The vaccine go by shoot a belittled fragment of the virus ’s genetic computer code , the mRNA , into the human body . This is used by the body ’s cells as instructions to bring on a certain protein of the computer virus . When this protein enter the bloodstream , our resistant organization is spark off and it learns how to get rid of the computer virus .
When the immune system encounters it again as an real computer virus , it recognizes the virus and mess with it quickly . It is presently unsure how long the immunity lasts .
For long - term storage , the Moderna Vaccine needs to be hold at a bass deep freezer temperature of -20 ° C/-4 ° F but can remain in a regular fridge for up to six months . Moderna believes that by the end of the month , it will have about 20 million doses of the vaccinum available in the U.S. In 2021 , the troupe expects to construct and ship between 500 million and 1 billion doses globally .
